Pacira Pharmaceuticals Inc-DE

21 de ago. de 2026, 19:56 UTC

Pacira Biosciences Inc. shares are higher during Friday's session, recovering from a midday dip amid positive sentiment in the broader market.

20 de ago. de 2026, 20:06 UTC

Pacira Biosciences Inc shares are lower today, continuing a decline from Wednesday's close. The stock remains below its 20-day moving average.

19 de ago. de 2026, 19:46 UTC

Pacira Biosciences Inc. shares are higher today, reflecting a broader market trend amid declining bond yields. The stock remains below its 20-day moving average.

18 de ago. de 2026, 20:03 UTC

Shares of Pacira Biosciences are higher, reflecting broader market strength. The stock remains below its 20-day moving average and near the lower end of its trading range.

17 de ago. de 2026, 19:26 UTC

Pacira Biosciences Inc shares are higher following Truist Securities' reinstatement of coverage with a Buy rating and a price target of $30.00.

14 de ago. de 2026, 19:36 UTC

Pacira Biosciences Inc shares are lower, marking the seventh consecutive decline. Broader market sentiment is affected by a reported drop in retail sales for July.

13 de ago. de 2026, 20:06 UTC

Pacira Biosciences Inc shares fell during Thursday's session, continuing a trend of declines and remaining below the 20-day moving average. No specific news was identified.

12 de ago. de 2026, 20:01 UTC

Pacira Biosciences Inc's shares are lower today, continuing a downward trend with a cumulative return of -3.36% since Tuesday. No specific news was identified.

11 de ago. de 2026, 19:16 UTC

Shares of Pacira Biosciences Inc. are lower today, continuing a trend of three consecutive declines. The stock is trading below its 20-day moving average.

10 de ago. de 2026, 19:36 UTC

Pacira Biosciences Inc is trading lower, continuing a decline since Friday. The stock remains below its 20-day moving average amid broader market volatility.

7 de ago. de 2026, 20:02 UTC

Pacira Biosciences shares are lower despite positive two-year Phase 1 trial results for PCRX-201, an investigational gene therapy for knee osteoarthritis.

6 de ago. de 2026, 19:52 UTC

Pacira Biosciences Inc. shares are higher following positive two-year results from its Phase 1 trial for PCRX-201, a gene therapy for knee osteoarthritis.

5 de ago. de 2026, 20:03 UTC

Pacira Biosciences reported improved earnings but lowered its 2026 revenue guidance, contributing to a decline in shares since Tuesday's close.

4 de ago. de 2026, 19:53 UTC

Pacira Biosciences Inc is higher today, supported by overall market strength and a decline in crude oil prices easing inflation concerns.

3 de ago. de 2026, 20:06 UTC

Pacira Biosciences Inc. shares are higher today, reflecting broader market gains led by major stocks, despite no specific company news identified.

31 de jul. de 2026, 20:02 UTC

Pacira Biosciences Inc's shares are lower today, reaching a session low earlier. The price remains above its 20-day moving average despite the decline.

30 de jul. de 2026, 17:16 UTC

Pacira Biosciences is advancing during Thursday's session, regaining momentum after earlier pulling back from a session high amid broader market optimism.

29 de jul. de 2026, 20:04 UTC

Shares of Pacira Biosciences Inc. are lower today, continuing a decline since Tuesday's close. The stock reached an early high before falling significantly.

28 de jul. de 2026, 19:56 UTC

Shares of Pacira Biosciences Inc. are higher, driven by survey findings on orthopedic pain's impact on the workforce and strong interest in non-opioid treatments.

27 de jul. de 2026, 18:51 UTC

Pacira Biosciences advances PCRX-201 to commercial manufacturing, allowing patient enrollment in Phase 2 ASCEND study. Shares are higher as investor confidence strengthens.

24 de jul. de 2026, 17:16 UTC

Pacira Biosciences Inc shares are lower today, with no specific news driving the decline. Broader market sentiment is impacted by falling crude oil prices.

22 de jul. de 2026, 18:06 UTC

Pacira Biosciences Inc shares are lower in Wednesday's session, pulling back from earlier gains amid broader market caution and rising crude oil prices.

21 de jul. de 2026, 19:56 UTC

Pacira Biosciences Inc is trading higher, reflecting broader market interest in technology and AI sectors ahead of upcoming earnings reports.

20 de jul. de 2026, 19:46 UTC

Pacira Biosciences Inc shares are trading lower today, having retraced from an earlier high. No specific news was identified to explain the decline.